Works by Barrau, Mathilde

Results: 24

What Should We Know about Drug Levels and Therapeutic Drug Monitoring during Pregnancy and Breastfeeding in Inflammatory Bowel Disease under Biologic Therapy?

Published in:

Journal of Clinical Medicine, 2023, v. 12, n. 23, p. 7495, doi. 10.3390/jcm12237495

By:

Barrau, Mathilde;
Roblin, Xavier;
Andromaque, Leslie;
Rozieres, Aurore;
Faure, Mathias;
Paul, Stéphane;
Nancey, Stéphane

Publication type:

Article

Development of Antibodies to Ustekinumab Is Associated with Loss of Response in Patients with Inflammatory Bowel Disease.

Published in:

Journal of Clinical Medicine, 2023, v. 12, n. 10, p. 3395, doi. 10.3390/jcm12103395

By:

Roblin, Xavier;
Duru, Gérard;
Papamichael, Konstantinos;
Cheifetz, Adam S.;
Kwiatek, Sandy;
Berger, Anne-Emmanuelle;
Barrau, Mathilde;
Waeckel, Louis;
Nancey, Stephane;
Paul, Stephane

Publication type:

Article

Predictive Factors of Cytomegalovirus Colonic Reactivation in Patients with Active Ulcerative Colitis.

Published in:

Viruses (1999-4915), 2025, v. 17, n. 4, p. 555, doi. 10.3390/v17040555

By:

Jentzer, Alexandre;
Cantais, Aymeric;
Roblin, Xavier;
Barrau, Mathilde;
Garcin, Arnauld;
Bourlet, Thomas;
Pozzetto, Bruno;
Pillet, Sylvie

Publication type:

Article

Avolition Characterizes the Chronic Fatigue Experienced in Quiescent Inflammatory Bowel Disease.

Published in:

Biomedicines, 2025, v. 13, n. 1, p. 125, doi. 10.3390/biomedicines13010125

By:

Gabriel-Segard, Tristan;
Boltri, Margherita;
Barrau, Mathilde;
Massoubre, Catherine;
Paul, Stéphane;
Roblin, Xavier

Publication type:

Article

Subcutaneous injection of infliximab CT‐P13 results in stable drug levels within 14‐day treatment cycle in Crohn's disease.

Published in:

Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 1, p. 77, doi. 10.1111/apt.16852

By:

Roblin, Xavier;
Veyrard, Pauline;
Bastide, Laetitia;
Berger, Anne E.;
Barrau, Mathilde;
Paucelle, Anne‐Sophie;
Waeckel, Louis;
Kwiatek, Sany;
Flourie, Bernard;
Nancey, Stephane;
Paul, Stéphane

Publication type:

Article

Early venous thromboembolism is a strong prognostic factor in patients with advanced pancreatic ductal adenocarcinoma.

Published in:

Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 11, p. 3447, doi. 10.1007/s00432-021-03590-x

By:

Barrau, Mathilde;
Maoui, Khawla;
Le Roy, Bertrand;
Roblin, Xavier;
Mismetti, Patrick;
Phelip, Jean-Marc;
Williet, Nicolas

Publication type:

Article

L'arrivée tant attendue des biothérapies ciblant l'IL-23 dans la prise en charge des MICI.

Published in:

Hépato-Gastro & Oncologie Digestive, 2025, v. 32, p. 6, doi. 10.1684/hpg.2025.2949

By:

Roblin, Xavier;
Barrau, Mathilde;
Mallard, Cyrielle;
Nancey, Stéphane

Publication type:

Article

L'arrivée des anti-IL23 se précise.

Published in:

2025

By:

Roblin, Xavier;
Barrau, Mathilde

Publication type:

Editorial

Médecine personnalisée et MICI : état des lieux en 2024.

Published in:

Hépato-Gastro & Oncologie Digestive, 2024, v. 31, p. 48, doi. 10.1684/hpg.2024.2895

By:

Roblin, Xavier;
Barrau, Mathilde;
Peaucelle, Anne Sophie

Publication type:

Article

L'importance de la rémission histologique dans les MICI est confirmée.

Published in:

Hépato-Gastro & Oncologie Digestive, 2024, v. 31, n. 10, p. 1113, doi. 10.1684/hpg.2024.2890

By:

Roblin, Xavier;
Barrau, Mathilde;
Peaucelle, Anne-Sophie;
Paul, Stéphane;
Mathieu, Nicolas

Publication type:

Article

Petites molécules et sécurité d'emploi dans les MICI.

Published in:

Hépato-Gastro & Oncologie Digestive, 2024, v. 31, n. 10, p. 1107, doi. 10.1684/hpg.2024.2888

By:

Roblin, Xavier;
Barrau, Mathilde;
Peaucelle, Anne-Sophie;
Paul, Stéphane;
Mathieu, Nicolas

Publication type:

Article

Biothérapies dans les MICI.

Published in:

Hépato-Gastro & Oncologie Digestive, 2024, v. 31, n. 10, p. 1133, doi. 10.1684/hpg.2024.2865

By:

Burgevin, Alice;
Duclaux-Loras, Rémi;
Charlois, Anne-Laure;
Barrau, Mathilde;
Faure, Mathias;
Nancey, Stéphane

Publication type:

Article

Quelle est la place des 5-aminosalicylés (5-ASA) dans le traitement des MICI à l'ère des biothérapies et des petites molécules ?

Published in:

Hépato-Gastro & Oncologie Digestive, 2024, v. 31, n. 5, p. 435, doi. 10.1684/hpg.2024.2776

By:

Roblin, Xavier;
Barrau, Mathilde

Publication type:

Article

Maladies inflammatoires chroniques intestinales, traitements médicamenteux et grossesse : Quoi de neuf en 2024 ?

Published in:

Hépato-Gastro & Oncologie Digestive, 2024, v. 31, n. 3, p. 342, doi. 10.1684/hpg.2024.2745

By:

Roblin, Xavier;
Barrau, Mathilde

Publication type:

Article

Vers une médecine personnalisée sous anti-TNF ? : pas encore...

Published in:

Hépato-Gastro & Oncologie Digestive, 2024, v. 31, n. 1, p. 29, doi. 10.1684/hpg.2023.2702

By:

Roblin, Xavier;
Barrau, Mathilde

Publication type:

Article

Vous avez dit SEQUENCE ?

Published in:

2024

By:

Roblin, Xavier;
Barrau, Mathilde;
Nancey, Stéphane

Publication type:

Editorial

Le concept du biobetter : un impact dans les MICI.

Published in:

Hépato-Gastro & Oncologie Digestive, 2023, v. 30, n. 7, p. 709, doi. 10.1684/hpg.2023.2617

By:

Roblin, Xavier;
Barrau, Mathilde

Publication type:

Article

Les différents protocoles des biothérapies dans la maladie de Crohn.

Published in:

Hépato-Gastro & Oncologie Digestive, 2023, v. 30, n. 6, p. 622, doi. 10.1684/hpg.2023.2600

By:

Roblin, Xavier;
Barrau, Mathilde;
Peaucelle, Anne-Sophie;
Paul, Stéphane

Publication type:

Article

Quelle place de la combothérapie précoce dans la prise en charge des MICI sévères ? Que faire en cas en cas de cancer récent ou actuel ? Des réponses récentes pour notre quotidien.

Published in:

Hépato-Gastro & Oncologie Digestive, 2023, v. 30, n. 5, p. 489, doi. 10.1684/hpg.2023.2592

By:

Roblin, Xavier;
Barrau, Mathilde

Publication type:

Article

Anti-TNF dans les MICI en mono- ou combothérapie : quand arrêter ou diminuer la dose ?

Published in:

Hépato-Gastro & Oncologie Digestive, 2023, v. 30, n. 4, p. 399, doi. 10.1684/hpg.2023.2585

By:

Roblin, Xavier;
Barrau, Mathilde

Publication type:

Article

Place des thiopurines dans la prise en charge des MICI en 2023.

Published in:

Hépato-Gastro & Oncologie Digestive, 2023, v. 30, n. 1, p. 40, doi. 10.1684/hpg.2023.2510

By:

Roblin, Xavier;
Barrau, Mathilde

Publication type:

Article

Proton pump inhibitors and risk of severe COVID-19 in older people.

Published in:

Age & Ageing, 2024, v. 53, n. 4, p. 1, doi. 10.1093/ageing/afae082

By:

Gramont, Baptiste;
Fayolle, Sophie;
Beltramin, Diva;
Bidat, Nisrine;
Boudet, Julie;
Chaux, Robin;
Grange, Lucile;
Barrau, Mathilde;
Gagneux-Brunon, Amandine;
Cathébras, Pascal;
Killian, Martin;
Botelho-Nevers, Elisabeth;
Célarier, Thomas

Publication type:

Article

Higher Serum Infliximab Concentrations Following Subcutaneous Dosing are Associated with Deep Remission in Patients with Inflammatory Bowel Disease.

Published in:

Journal of Crohn's & Colitis, 2024, v. 18, n. 5, p. 679, doi. 10.1093/ecco-jcc/jjad188

By:

Roblin, Xavier;
Nancey, Stéphane;
Papamichael, Konstantinos;
Duru, Gérard;
Flamand, Mathurin;
Kwiatek, Sandy;
Cheifetz, Adam;
Fabien, Nicole;
Barrau, Mathilde;
Paul, Stéphane

Publication type:

Article

A Systematic Review on the Interest of Drug-tolerant Assay in the Monitoring of Inflammatory Bowel Disease.

Published in:

Journal of Crohn's & Colitis, 2023, v. 17, n. 4, p. 633, doi. 10.1093/ecco-jcc/jjac164

By:

Barrau, Mathilde;
Duprat, Manon;
Veyrard, Pauline;
Tournier, Quentin;
Williet, Nicolas;
Phelip, Jean Marc;
Waeckel, Louis;
Cheifetz, Adam S;
Papamichael, Konstantinos;
Roblin, Xavier;
Paul, Stephane

Publication type:

Article